See the variables the protocol can miss.
Clinical research strategy connecting participant biology, recruitment, real-world interpretation, scientific communication, ethical medical marketing, and healthcare adoption.
I work best where research, participant behavior, and market interpretation overlap. The goal is to identify what may confound the study, what the participant journey reveals, and how the evidence will be understood after publication.
Disease defines the cohort. Biology still shapes the response.
Same diagnosis does not mean same biological starting point.
Participants can enter with different metabolic states, treatment histories, sleep patterns, supplement stacks, environmental exposures, behaviors, and physiological reserve.
Depending on the question, those differences may affect response, tolerance, adherence, dropout, or interpretation.
Identify the biology that should become common study context.
The objective is not to measure everything. It is to identify which variables deserve measurement, stratification, documentation, subgroup analysis, or future study.
That makes the protocol more precise about what was controlled, what remained heterogeneous, and how far the conclusion can travel.
Reduction is useful. Overextension is not.
Sunlight does not arrive as isolated UVB.
Isolating one wavelength may be the correct design for a narrow mechanistic question. The problem begins when that isolated exposure is treated as equivalent to the full solar environment.
Ask what the experiment intentionally removed.
Outdoors, wavelength, intensity, timing, heat, spectral ratios, prior adaptation, and behavior interact. A narrow experiment can answer one question while leaving the real-world exposure unresolved.
I apply the same logic across clinical research: preserve the value of reduction without forgetting the context that disappears with it.
What happens to the research after publication matters.
Research becomes excerpts, clinical conversations, product claims, social posts, investor narratives, patient decisions, and market expectations.
What will readers think it means?
Anticipate how clinicians, patients, media, investors, and creators will interpret the finding outside the paper.
What disappears in the excerpt?
Identify the methods, caveats, population limits, timing, dose, and uncertainty most likely to vanish in summaries.
What will the market ask next?
Help products and technologies anticipate future clinical questions, adoption barriers, evidence gaps, and follow-up studies.
The participant journey is part of the research environment.
Director of Clinical Trial Recruitment Campaigns.
My work at THREAD, a decentralized clinical trial platform, centered on patient motivation, screening friction, remote participation, caregiver concerns, technology expectations, conversion flow, and compliant communication.
That experience still shapes how I read a protocol from the participant's side.
Recruitment data can reveal more than campaign performance.
Drop-off, confusion, abandoned screening, slow follow-up, caregiver burden, and technology friction can expose a mismatch between study design and the population the study needs.
Understanding why people enroll, decline, or disappear improves both recruitment strategy and research design.
Make the evidence clearer, not easier to exaggerate.
Protect the scientific spine.
Marketing should distinguish mechanism from outcome, early evidence from established evidence, and a narrow study conclusion from a broad product claim.
Use visibility without turning research into influencer content.
My digital background includes healthcare content, social media, audience development, acquisition, conversion, and stakeholder engagement.
The value is not reach alone. It is understanding how a finding will travel, where it may be distorted, and how to build visibility that remains credible when the evidence evolves.
One scientific core across several functions.
Evidence synthesis
Literature review, research gaps, protocol assumptions, participant context, and external validity.
Recruitment strategy
Patient motivation, screening, decentralized participation, conversion, retention, and participant communication.
Adoption strategy
Connect evidence to clinical relevance, patient understanding, product questions, and real-world use.
Scientific translation
Translate one evidence base for patients, clinicians, executives, partners, media, and market audiences.
Content & social
Long-form publishing, professional social media, audience education, healthcare digital strategy, and engagement.
Cross-functional fit
Work across research, product, recruitment, communication, and market development without losing the clinical context.
More useful than a narrow technical role when the work crosses departments.
Research, recruitment, digital strategy, and healthcare communication.
My background combines medical education, long-form research analysis, clinical trial recruitment, healthcare startups, digital marketing, scientific communication, and market development.
Useful across research, product, participant, and market conversations.
Consulting, advisory, embedded, or selected full-time roles.
For organizations improving how research is designed and interpreted.
Best fit where participant biology, evidence synthesis, real-world context, protocol assumptions, and downstream interpretation matter to the study.
For organizations improving how participants enter and stay in research.
Best fit where recruitment strategy, decentralized participation, patient translation, screening friction, conversion, or retention affect performance.
For medtech, diagnostics, digital health, and healthcare startups.
Best fit where evidence must become clinician relevance, patient understanding, market confidence, and responsible product adoption.
For organizations that need research-led public credibility.
Best fit where long-form content, professional social media, scientific communication, stakeholder education, and ethical medical marketing support the larger strategy.
If the role sits between research, participants, product, and communication, I want to hear about it.
I am open to selected consulting, contract, advisory, and full-time opportunities where cross-functional clinical research judgment is more valuable than another isolated specialty.
Best Is Me provides research, strategy, evidence interpretation, scientific communication, participant-recruitment strategy, market-development support, and advisory services. These services do not replace formal biostatistical analysis, regulatory review, sponsor responsibilities, investigator oversight, legal review, medical decision-making, or other regulated functions.